Uresil
Private Company
Funding information not available
Overview
UreSil is a well-established, privately-held medical device company with over four decades of experience in the minimally invasive procedure market. It operates as a fully integrated entity, handling development, manufacturing, and global distribution of its product portfolio, which includes drainage catheters, stents, and pneumothorax kits. The company has a significant global sales force and is experiencing growing market demand through expanded group purchasing organization (GPO) and integrated delivery network (IDN) relationships. Its strategic expansion into CT, ultrasound, and emergency care has solidified its position as a leader in the fluid drainage market.
Technology Platform
Integrated medical device design, engineering, and manufacturing for minimally invasive drainage and access procedures, with expertise in catheter-based systems.
Opportunities
Risk Factors
Competitive Landscape
UreSil competes in the specialized fluid drainage market against large, diversified medtech companies (e.g., Boston Scientific, Cook Medical) and other niche players. Its competitive advantage lies in its focused expertise, reputation for solving complex problems, and agility as an integrated, private manufacturer.